Stock Events

Stock Events

Avalo Therapeutics (AVTX) Q2 2026 Earnings

13MayConfirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-2.19

-1.79

-1.38

-0.98

Details

Expected EPS

-1.025344

Actual EPS

-0.98

Surprise EPS

0.05

Surprise Percent

+4.42%

Description

Avalo Therapeutics (AVTX) has reported earnings of -0.98 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.